Catheter Precision (VTAK) EPS (Weighted Average and Diluted) (2021 - 2022)
Catheter Precision (VTAK) reported EPS (Weighted Average and Diluted) of $2.02 for Q4 2022, up 105.4% year-over-year from $0.98 in Q4 2021, and up 146.33% quarter-over-quarter from -$4.36 in Q3 2022.
Catheter Precision (VTAK) EPS (Weighted Average and Diluted) (2021 - 2022) Analysis & Trends
Catheter Precision (VTAK) has 2 years of EPS (Weighted Average and Diluted) data on file, last reported at $2.02 in Q4 2022.
- EPS (Weighted Average and Diluted) for Q4 2022 came in at $2.02, up 105.4% year-over-year; the trailing twelve-month figure through Dec 2022 was -$97.38 (down 289.06% YoY), and the FY2022 annual result was -$25.98, up 89.53% from the prior year.
- EPS (Weighted Average and Diluted) rose to $2.02 in Q4 2022 per VTAK's latest filing, from -$4.36 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $2.02 in Q4 2022 and troughed at -$57.64 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Catheter Precision | 921,210.28 | 109,210.28 | 390,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.02 |
| Sep 30, 2022 | -4.36 |
| Dec 31, 2021 | -37.40 |
| Sep 30, 2021 | -57.64 |